Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
about
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurementsThe pathology of unusual subtypes of prostate cancerCancer biomarker discovery: the entropic hallmark.Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.Phytanic acid, AMACR and prostate cancer risk.Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue.Primary signet ring cell carcinoma of the prostate.Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.The spectrum of morphology in non-neoplastic prostate including cancer mimics.Histological variants of prostatic carcinoma and their significance.Histopathology of Prostate Cancer.Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnosticsMolecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate.Diagnostic biomarkers of prostate cancer.Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions.Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.Variants of acinar adenocarcinoma of the prostate mimicking benign conditions.Prostate cancer: diagnostic criteria and role of immunohistochemistry.Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.Pseudohyperplastic Adenocarcinoma With Foamy Changes in Needle Prostate Biopsy and Prostatectomy.Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.
P2860
Q24673038-D78B9A65-AE65-4B6C-80D9-5BE9E74785C1Q26752906-67002DBF-2C91-4917-9D3C-5164A4C6A57CQ30496149-7FBF7F9F-0ABC-4153-B43C-829ED324CA7BQ36329324-5C4D345A-1B21-4DA6-B50E-90B9DE758D3DQ36430735-3022975D-5840-4339-862F-9661CC427064Q36443528-79988720-CEC7-4A91-B5B8-561023EA6D09Q37814775-96D7849E-2155-4E40-BE12-5A77EFF6417AQ37878470-26380EC0-228F-48B7-B159-59056B8E36C6Q37972699-9134EDAE-A6E1-4EE1-AFF9-ADD111787555Q37972700-A2009291-C7D2-492F-9B33-C02747E6518FQ39227648-EF131B99-A4CB-4F44-8598-A5956B652E5BQ41307496-F9562FA4-29E3-43B8-AB6F-4892F4BF7B9EQ41981512-C63F184A-A2E4-4A26-A9A0-76E420F8BD47Q42184292-70D09447-11A1-4A6C-A848-078A48B0205CQ42463376-B0E9B9BE-2174-4BA8-BC2C-984514A847B3Q42479099-016596EE-8211-48C3-A703-03F20A24F40CQ42494027-4964C049-47E2-4C65-A055-A3DE887AD954Q42513914-573C03A7-D37D-4707-81B2-2837A361D2CCQ43185634-B62D8EC3-6049-4C2F-8467-7916A7291FACQ49347797-4C078705-3C1F-4B7A-9CB0-F719041A3210Q49347844-2E6960FA-A022-45DB-9F68-0B3D791B945AQ50510865-86216FE6-A3D1-4D35-9FC9-751759915BFBQ50603044-657A896E-3AD2-497B-B6E9-9EFCD266978FQ51560512-3E594F7A-62CF-429D-A3ED-658030185441Q53135859-446D1CF1-BC6B-4A42-9246-BF6FA6A1F4D1Q54377548-3301CEB4-58C0-491F-8881-7BDADE4E3FE2
P2860
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@ast
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@en
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase
@nl
type
label
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@ast
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@en
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase
@nl
prefLabel
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@ast
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@en
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase
@nl
P2093
P1476
Expression and diagnostic util ...... ohyperplastic prostate cancer.
@en
P2093
Jonathan I Epstein
Zhong Jiang
P304
P356
10.1097/00000478-200306000-00007
P407
P577
2003-06-01T00:00:00Z